基本信息
浏览量:37
职业迁徙
个人简介
Kimiyuki ShibuyaPh.D. is currently working as a Medicinal Chemist at the Tokyo New Drug Research Laboratories, Kowa company. He has been engaged in drug discovery program and discovered several drug candidates (K code number is clinical candidate compound: K-604, K-877 (pemafibrate), K-312, K-115 (Glanatec) and LXRbeta selective agonist etc) since 1994. He was assigned to manage many research programs in the department of organic chemistry and retired from MedChem Dept. on April 2015. He has been promoting to study 2 research projects (Alzheimer’s disease & Glioblastoma) using ACAT-1 selective inhibitor, K-604 as a clinical candidate. Recently he has developed and applied a patent (WO2018/092765: the intranasal administration method to deliver K-604 into the brain efficiently).
研究兴趣
论文共 106 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Bioorganic & Medicinal Chemistryno. 14 (2018): 4001-4013
Bioorganic & medicinal chemistryno. 16 (2016): 3446
引用0浏览0引用
0
0
Acta crystallographica. Section E, Crystallographic communicationsno. Pt 2 (2016): 184-7
加载更多
作者统计
#Papers: 107
#Citation: 2141
H-Index: 24
G-Index: 32
Sociability: 5
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn